What are the only FDA approved ADF opioids?

The correct choice identifies all the FDA-approved abuse-deterrent formulation (ADF) opioids, which include Xtampza ER, Oxycontin, Embeda, Arymo, MorphaBond, and Hysingla. The reason this option is correct lies in the critical role these medications play in addressing the opioid crisis through measures that reduce the potential for misuse and abuse.

Xtampza ER is specifically designed to deter abuse by providing a controllable release of medication that cannot be easily crushed. Oxycontin, an extended-release formulation, has also been reformulated to include abuse-deterrent properties. Embeda combines morphine with naltrexone to reduce the likelihood of abuse through injection. Arymo, another formulation, is designed to be more difficult to manipulate for misuse.

MorphaBond and Hysingla are included because they have also been approved with a focus on deterring misuse by addressing the unique methods through which patients might attempt to abuse these opioids, such as by crushing for rapid administration.

This comprehensive list of medications developed with abuse-deterrent strategies illustrates a significant advancement in the approach to prescribing opioids, reflecting a growing awareness and responsibility to mitigate the risks of opioid addiction and misuse. Each drug's A